Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study.

Keser I, Straus S, Imamovic D, Ismic N, Jamakosmanovic A, Omic Salkic D, Sotonica M, Mihalj M

Open source

DOI
10.7759/cureus.116579
Published
2026 Sep
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.116579,
  title = {Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study.},
  author = {Keser I and Straus S and Imamovic D and Ismic N and Jamakosmanovic A and Omic Salkic D and Sotonica M and Mihalj M},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.116579},
  url = {https://doi.org/10.7759/cureus.116579}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study.
AU  - Keser I
AU  - Straus S
AU  - Imamovic D
AU  - Ismic N
AU  - Jamakosmanovic A
AU  - Omic Salkic D
AU  - Sotonica M
AU  - Mihalj M
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.116579
UR  - https://doi.org/10.7759/cureus.116579
ER  - 

APA

I, K., S, S., D, I., N, I., A, J., D, O. S., M, S., & M, M. (2026). Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study.. Cureus. https://doi.org/10.7759/cureus.116579

Source records